Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

True, MNTA gives its cash-usage guidance in an odd sort of way in order to avoid having to make an explicit call on Lovenox royalties. It’s pretty easy to back into the actual bottom-line figure, however.